JP2013531784A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531784A5
JP2013531784A5 JP2013510677A JP2013510677A JP2013531784A5 JP 2013531784 A5 JP2013531784 A5 JP 2013531784A5 JP 2013510677 A JP2013510677 A JP 2013510677A JP 2013510677 A JP2013510677 A JP 2013510677A JP 2013531784 A5 JP2013531784 A5 JP 2013531784A5
Authority
JP
Japan
Prior art keywords
polypeptide
panel
concentration
brain injury
comprises assaying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013510677A
Other languages
English (en)
Japanese (ja)
Other versions
JP5775568B2 (ja
JP2013531784A (ja
Filing date
Publication date
Priority claimed from GBGB1008541.3A external-priority patent/GB201008541D0/en
Application filed filed Critical
Publication of JP2013531784A publication Critical patent/JP2013531784A/ja
Publication of JP2013531784A5 publication Critical patent/JP2013531784A5/ja
Application granted granted Critical
Publication of JP5775568B2 publication Critical patent/JP5775568B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013510677A 2010-05-21 2011-05-23 診断方法 Expired - Fee Related JP5775568B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1008541.3 2010-05-21
GBGB1008541.3A GB201008541D0 (en) 2010-05-21 2010-05-21 Diagnostic methods
PCT/GB2011/000784 WO2011144914A2 (en) 2010-05-21 2011-05-23 Diagnostic methods

Publications (3)

Publication Number Publication Date
JP2013531784A JP2013531784A (ja) 2013-08-08
JP2013531784A5 true JP2013531784A5 (enExample) 2014-05-08
JP5775568B2 JP5775568B2 (ja) 2015-09-09

Family

ID=42341144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013510677A Expired - Fee Related JP5775568B2 (ja) 2010-05-21 2011-05-23 診断方法

Country Status (7)

Country Link
US (1) US20130252834A1 (enExample)
EP (1) EP2572202A2 (enExample)
JP (1) JP5775568B2 (enExample)
AU (1) AU2011254386B2 (enExample)
CA (1) CA2800038A1 (enExample)
GB (1) GB201008541D0 (enExample)
WO (1) WO2011144914A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012051519A2 (en) * 2010-10-14 2012-04-19 The Johns Hopkins University Biomarkers of brain injury
US20140141458A1 (en) 2011-05-12 2014-05-22 The Johns Hopkins University Assay reagents for a neurogranin diagnostic kit
US20140377763A1 (en) * 2012-01-12 2014-12-25 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Brain damage marker
HK1206425A1 (en) 2012-03-13 2016-01-08 The Johns Hopkins University Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
US10534003B2 (en) 2013-07-17 2020-01-14 The Johns Hopkins University Multi-protein biomarker assay for brain injury detection and outcome
CN103432574B (zh) * 2013-08-25 2015-04-08 浙江大学 一种过氧化物酶在制备防治脑血管疾病药物中的应用
WO2015038784A1 (en) * 2013-09-13 2015-03-19 The Board Of Trustees Of The Leland Stanford Junior University Multiplexed imaging of tissues using mass tags and secondary ion mass spectrometry
WO2016055148A2 (en) * 2014-10-06 2016-04-14 Université De Genève Markers and their use in brain injury
WO2017174557A2 (en) 2016-04-04 2017-10-12 Brains Online Holding B.V. Use of push pull microdialysis in combination with shotgun proteomics for analyzing the proteome in extracellular space of brain
WO2018148294A2 (en) * 2017-02-07 2018-08-16 Bioregency, Inc. S100β AND ISOFORMS FOR DETECTION OF NEUROLOGICAL CONDITIONS
CN107748263A (zh) * 2017-08-31 2018-03-02 北京臻惠康生物科技有限公司 一种纤维蛋白溶酶原的新用途及试剂盒
CN109536469B (zh) * 2018-11-23 2021-02-09 北华大学 突变改造Prx6蛋白及其表达基因、制备方法和应用
WO2021163608A2 (en) * 2020-02-14 2021-08-19 Galaxy Ccro, Inc. Devices and methods for treating ischaemia and acute respiratory distress syndromes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
DK2341350T3 (en) * 2003-09-20 2018-02-05 Electrophoretics Ltd DIAGNOSTIC PROCEDURE FOR BRAKE INJURY-RELATED DISORDERS BASED ON DJ-1 DETECTION
US20080307537A1 (en) * 2005-03-31 2008-12-11 Dana-Farber Cancer Institute, Inc. Compositions and Methods for the Identification, Assessment, Prevention, and Therapy of Neurological Diseases, Disorders and Conditions
JP4521512B2 (ja) * 2005-06-15 2010-08-11 独立行政法人産業技術総合研究所 痴呆症の診断方法及び診断キット
GB2428240A (en) * 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
AU2007284651B2 (en) * 2006-08-09 2014-03-20 Institute For Systems Biology Organ-specific proteins and methods of their use

Similar Documents

Publication Publication Date Title
JP2013531784A5 (enExample)
JP2019530875A5 (enExample)
JP7285215B2 (ja) 大腸がんを検出するためのバイオマーカー
Lim et al. Electrochemical peptide sensor for diagnosing adenoma-carcinoma transition in colon cancer
RU2011150279A (ru) Фосфодиэстераза 4d7 как маркер рака предстательной железы
HRP20250210T1 (hr) Analiza za antitijela jc virusa
Madian et al. Mass-linked immuno-selective assays in targeted proteomics
JP2012501318A5 (enExample)
RU2012110372A (ru) Идентификация и количественное определение биомаркеров для оценки риска преждевременных родов
JP2011520108A5 (enExample)
Aita et al. Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: Innate immunity, taste perception and FABP5 proteins make the difference
JP2005538360A5 (enExample)
JP4452715B2 (ja) 特定のペプチドを自閉症の指標として利用する方法
WO2007005946A3 (en) Detection of rho proteins
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
Treitz et al. Combination of a SAW-biosensor with MALDI mass spectrometric analysis
KR20140002149A (ko) 췌장암 진단용 마커 및 이의 용도
AU2016342546B2 (en) Use of a fibrinogen capture agent to detect a Ciz1 b-variant
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
JP2006522336A5 (enExample)
CN110257388B (zh) 一种特异性识别精氨酸的多肽适配体及应用
CA2837522A1 (en) Biomarkers for autoimmune liver diseases and uses thereof
JP2011528799A5 (enExample)
EP3132269A2 (en) Diagnosis of chronic kidney disease by quantitative analysis of post-translational modifications of plasma proteins
US20100035263A1 (en) Biomarkers for renal disease